Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics

X-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects,...

Full description

Bibliographic Details
Main Authors: Hayden Winter, Megan J. Neufeld, Lydia Makotamo, Conroy Sun, Andrea M. Goforth
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/10/8/1447
id doaj-d73a8270d1444576ac873f231a0bb8ce
record_format Article
spelling doaj-d73a8270d1444576ac873f231a0bb8ce2020-11-25T02:35:09ZengMDPI AGNanomaterials2079-49912020-07-01101447144710.3390/nano10081447Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based TheranosticsHayden Winter0Megan J. Neufeld1Lydia Makotamo2Conroy Sun3Andrea M. Goforth4Department of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USADepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USADepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USAX-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects, new classes of nanoparticles are being developed to enhance reactive oxygen species production during irradiation. This report presents the synthesis and radiotherapeutic efficacy evaluation of a new nanoparticle formulation designed for this purpose, composed of a CaF<sub>2</sub> core, mesoporous silica shell, and polyethylene glycol coating. The construct was additionally doped with Tb and Eu during the CaF<sub>2</sub> core synthesis to prepare nanoparticles (NPs) with X-ray luminescent properties for potential application in fluorescence imaging. The mesoporous silica shell was added to provide the opportunity for small molecule loading, and the polyethylene glycol coating was added to impart aqueous solubility and biocompatibility. The potential of these nanomaterials to act as radiosensitizers for enhancing X-ray radiotherapy was supported by reactive oxygen species generation assays. Further, in vitro experiments indicate biocompatibility and enhanced cellular damage during X-ray radiotherapy.https://www.mdpi.com/2079-4991/10/8/1447CaF<sub>2</sub>mesoporous silicananoparticlecore-shelllanthanide-dopedpolyethylene glycol
collection DOAJ
language English
format Article
sources DOAJ
author Hayden Winter
Megan J. Neufeld
Lydia Makotamo
Conroy Sun
Andrea M. Goforth
spellingShingle Hayden Winter
Megan J. Neufeld
Lydia Makotamo
Conroy Sun
Andrea M. Goforth
Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
Nanomaterials
CaF<sub>2</sub>
mesoporous silica
nanoparticle
core-shell
lanthanide-doped
polyethylene glycol
author_facet Hayden Winter
Megan J. Neufeld
Lydia Makotamo
Conroy Sun
Andrea M. Goforth
author_sort Hayden Winter
title Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
title_short Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
title_full Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
title_fullStr Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
title_full_unstemmed Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
title_sort synthesis of radioluminescent caf<sub>2</sub>:ln core, mesoporous silica shell nanoparticles for use in x-ray based theranostics
publisher MDPI AG
series Nanomaterials
issn 2079-4991
publishDate 2020-07-01
description X-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects, new classes of nanoparticles are being developed to enhance reactive oxygen species production during irradiation. This report presents the synthesis and radiotherapeutic efficacy evaluation of a new nanoparticle formulation designed for this purpose, composed of a CaF<sub>2</sub> core, mesoporous silica shell, and polyethylene glycol coating. The construct was additionally doped with Tb and Eu during the CaF<sub>2</sub> core synthesis to prepare nanoparticles (NPs) with X-ray luminescent properties for potential application in fluorescence imaging. The mesoporous silica shell was added to provide the opportunity for small molecule loading, and the polyethylene glycol coating was added to impart aqueous solubility and biocompatibility. The potential of these nanomaterials to act as radiosensitizers for enhancing X-ray radiotherapy was supported by reactive oxygen species generation assays. Further, in vitro experiments indicate biocompatibility and enhanced cellular damage during X-ray radiotherapy.
topic CaF<sub>2</sub>
mesoporous silica
nanoparticle
core-shell
lanthanide-doped
polyethylene glycol
url https://www.mdpi.com/2079-4991/10/8/1447
work_keys_str_mv AT haydenwinter synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics
AT meganjneufeld synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics
AT lydiamakotamo synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics
AT conroysun synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics
AT andreamgoforth synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics
_version_ 1724805157941673984